Condition: MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease) · Sponsor: Nantes University Hospital
The objective of this study is to demonstrate that an \< or equal to 8-hour time-restricted eating (i.e., fasting for at least 16 hours every day), not focusing on reducing caloric intake, reduces intra-hepatic fat in patients with obesity and Metabolic dysfunction-Associated Steatotic liver Disease (MASLD).
This description comes directly from the study's public registry record.
David JACOBI, MD · 02 53 48 27 01 · david.jacobi@chu-nantes.fr
Always discuss trial participation with your own doctor first.
| CHU Angers | Angers, France | Not Yet Recruiting |
| CHU Bordeaux | Bordeaux, France | Not Yet Recruiting |
| CHU Dijon-Bourgogne | Dijon, France | Not Yet Recruiting |
| CHU Lyon | Lyon, France | Not Yet Recruiting |
| CHU Marseille | Marseille, France | Not Yet Recruiting |
| CHU Montpellier | Montpellier, France | Not Yet Recruiting |
| CHU Nantes | Nantes, France | Recruiting |
| Hôpital Européen Georges Pompidou | Paris, France | Not Yet Recruiting |
| CHU Rennes | Rennes, France | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07378072